Critical steps in alkylation-induced aberration formation

被引:44
作者
Kaina, B [1 ]
机构
[1] Inst Toxicol, Div Appl Toxicol, D-55131 Mainz, Germany
关键词
chromosomal aberration; DNA repair; DNA damage; alkylating agent; DNA replication inhibition;
D O I
10.1016/S0027-5107(98)00103-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The process leading to chromosomal aberrations as a consequence of DNA damage is probably best understood for simple alkylating agents. Various functions have been identified which are involved in the conversion of critical primary lesions to aberrations. O-6-methylguanine is considered to be an important critical preclastogenic DNA lesion, which is converted to aberrations in conjunction with faulty mismatch repair. It operates at sites of O-6-methylguanine-thymine mispairing, leading to not yet defined secondary lesions. It is proposed that these secondary lesions cause DNA replication inhibition, which triggers recombination (sister-chromatid exchange formation)and is a critical event involved in aberration production in the second post-treatment replication cycle. For N-alkylations, DNA replication inhibition may result from depurinations and base excision repair intermediates causing a block of replication. In consequence, sister-chromatid exchanges as well as chromosomal aberrations are formed in the first post-treatment replication cycle. Data are available to show that DNA replication inhibition and aberration production in the first post-treatment replication cycle are interrelated. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 25 条
  • [1] CHROMOSOME-ABERRATIONS - PERSISTENCE OF ALKYLATION DAMAGE AND MODULATION BY O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
    BEAN, CL
    BRADT, CI
    HILL, R
    JOHNSON, TE
    STALLWORTH, M
    GALLOWAY, SM
    [J]. MUTATION RESEARCH, 1994, 307 (01): : 67 - 81
  • [2] DISTRIBUTION OF METHYL AND ETHYL ADDUCTS FOLLOWING ALKYLATION WITH MONOFUNCTIONAL ALKYLATING-AGENTS
    BERANEK, DT
    [J]. MUTATION RESEARCH, 1990, 231 (01): : 11 - 30
  • [3] DEFECTIVE MISMATCH BINDING AND A MUTATOR PHENOTYPE IN CELLS TOLERANT TO DNA DAMAGE
    BRANCH, P
    AQUILINA, G
    BIGNAMI, M
    KARRAN, P
    [J]. NATURE, 1993, 362 (6421) : 652 - 654
  • [4] INACTIVATION OF THE MOUSE MSH2 GENE RESULTS IN MISMATCH REPAIR DEFICIENCY, METHYLATION TOLERANCE, HYPERRECOMBINATION, AND PREDISPOSITION TO CANCER
    DEWIND, N
    DEKKER, M
    BERNS, A
    RADMAN, M
    RIELE, HT
    [J]. CELL, 1995, 82 (02) : 321 - 330
  • [5] Mismatch G-T binding activity and MSH2 expression is quantitatively related to sensitivity of cells to methylating agents
    Dosch, J
    Christmann, M
    Kaina, B
    [J]. CARCINOGENESIS, 1998, 19 (04) : 567 - 573
  • [6] A ROLE FOR MISMATCH REPAIR IN PRODUCTION OF CHROMOSOME-ABERRATIONS BY METHYLATING AGENTS IN HUMAN-CELLS
    GALLOWAY, SM
    GREENWOOD, SK
    HILL, RB
    BRADT, CI
    BEAN, CL
    [J]. MUTATION RESEARCH LETTERS, 1995, 346 (04): : 231 - 245
  • [7] C-FOS IS INVOLVED IN THE CELLULAR DEFENSE AGAINST THE GENOTOXIC EFFECT OF UV-RADIATION
    HAAS, S
    KAINA, B
    [J]. CARCINOGENESIS, 1995, 16 (05) : 985 - 991
  • [8] POTENTIATION OF X-RAY AND STREPTONIGRIN-INDUCED CHROMOSOMAL-ABERRATIONS IN HUMAN-LYMPHOCYTES BY POST-TREATMENTS WITH HYDROXYUREA AND CAFFEINE
    HANSSON, K
    PALITTI, F
    KIHLMAN, BA
    KARLSSON, MB
    [J]. HEREDITAS, 1982, 97 (01) : 51 - 58
  • [9] HILL AB, 1985, CANCER RES, V45, P5050
  • [10] HONSLO JK, 1990, MUTAGENESIS, V5, P475